Meridian Bioscience, Inc.
Meridian Bioscience, Inc., a leading player in the life sciences industry, is headquartered in the United States. Founded in 1976, the company has established itself as a key provider of diagnostic products and life science reagents, primarily focusing on infectious disease testing and molecular diagnostics. With a strong presence in North America and Europe, Meridian Bioscience is renowned for its innovative solutions, including its proprietary immunoassay and molecular technologies. The company’s commitment to quality and accuracy has positioned it as a trusted partner in the healthcare sector. Notable achievements include significant advancements in rapid testing methodologies, which have enhanced patient care and diagnostic efficiency. Meridian Bioscience continues to drive progress in the industry, making it a pivotal entity in the realm of bioscience.
DitchCarbon Score
How does Meridian Bioscience, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Meridian Bioscience, Inc.'s score of 25 is lower than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Meridian Bioscience, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of SD Biosensor, Inc., which may influence its climate-related initiatives and reporting. While there are no documented reduction targets or climate pledges from Meridian Bioscience, it is important to note that emissions data and climate commitments may be inherited from its parent company, SD Biosensor, Inc. However, specific details regarding these initiatives or targets have not been disclosed. As a participant in the biotechnology sector, Meridian Bioscience is positioned within an industry increasingly focused on sustainability and carbon reduction. The lack of specific emissions data highlights an opportunity for the company to enhance its transparency and commitment to climate action.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 1,335,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 11,402,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Meridian Bioscience, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
